carbidopa/levodopa "2care4" 25+100 mg tabletter
2care4 aps - carbidopamonohydrat, levodopa - tabletter - 25+100 mg
inbrija
acorda therapeutics ireland limited - levodopa - parkinsons sygdom - anti-parkinson-lægemidler - inbrija er angivet for den intermitterende behandling af episodisk motoriske fluktuationer (off episoder) hos voksne patienter med parkinsons sygdom (pd) behandles med levodopa/dopa-decarboxylase inhibitor.
carbidopa/levodopa "nordic prime" 25+100 mg tabletter
nordic prime aps - carbidopa, levodopa - tabletter - 25+100 mg
carbidopa/levodopa "orion" 12,5+50 mg tabletter
orion corporation - carbidopamonohydrat, levodopa - tabletter - 12,5+50 mg
dentocaine 40+0,01 mg/ml injektionsvæske, opløsning
inibsa dental s.l.u. - adrenalintartrat, articainhydrochlorid - injektionsvæske, opløsning - 40+0,01 mg/ml
duodopa 20+5 mg/ml enteralgel
abbvie a/s - carbidopa, levodopa - enteralgel - 20+5 mg/ml
fentanyl "hameln" 50 mikrogram/ml injektionsvæske, opløsning
hameln pharma gmbh - fentanylcitrat - injektionsvæske, opløsning - 50 mikrogram/ml
flexilev 5+1,25 mg dispergible tabletter til dosisdispenser
sensidose ab - carbidopamonohydrat, levodopa - dispergible tabletter til dosisdispenser - 5+1,25 mg
levodopa/carbidopa "teva" 200+50 mg depottabletter
teva b.v. - carbidopamonohydrat, levodopa - depottabletter - 200+50 mg
carbidopa/levodopa "fair-med" 25+100 mg tabletter
orifarm a/s - carbidopa, levodopa - tabletter - 25+100 mg